The R & D work of Omicor Rong's Vaccine is steadily promoting

China News Service, Beijing, July 23 (Reporter Li Chun) Feng Zijian, Executive Vice President and Secretary -General of the Chinese Association of Prevention Medical Association, said at the joint defense joint control mechanism conference on the 23rd that the research and development of Omicor Rong mutant plants is steadily steadily For advancement, as long as there is a need, in accordance with the requirements of relevant regulations, you can quickly start the emergency use approval procedure and provide vaccination.

Feng Zijian said that from December 26, 2021, the State Council ’s joint prevention and control mechanism science and technology group vaccine research and development class, that is, the World Health Organization listed Omikon variants as a mutated plant that attracted much attention. At present, many technical routes have been carried out for the research and development of the unit price and multi -price Omikon mutant plant.

He introduced that the fast -moving unit price of Omikon variants has been approved by clinical trials. Clinical trials are being carried out in Zhejiang, Hunan, Hong Kong and other places. Test approval, related studies have been started, and many other unit prices, multi -price containing Omecko mutations, restructuring protein vaccines, adenovirus vectors vaccine, and MRNA vaccine are also conducting pre -clinical research. The Drug Approval Center submits clinical trial declaration information. In addition, the special class also deployed the research on the new -spectrum vaccine, and the rapid progress of vaccine has been approved by clinical trials and launched related research.

"In general, the research and development of Omikon's Vaccination of Omikon mutation is steadily promoted. As long as there is a need, in accordance with the requirements of relevant regulations, the emergency approval procedure can be started to provide vaccination." When the vaccine containing Omircor's mutation strains is not only in China, but also internationally study, mainly to study virus mutation and immune escape.

Feng Zijian also said that the results of multiple studies showed that the effects of existing vaccines at home and abroad still maintained a high level. Chinese vaccines still have a good protective effect on the severe disease and death caused by the mutant strains, and strengthening immunity can further reduce the risk of hospitalization, severe and death.

He also said that the real world research on the prevention effect of domestic vaccines in Hong Kong and the Mainland showed that the effect of vaccination with severe and death was still good. A study by the University of Hong Kong shows that the elderly over 60 years of age to complete the two doses of domestic excessive vaccines are 69.9%of the protection of severe illnesses and deaths. After completing the third pins, 97.9%.

- END -